Discussion of “Some Controversial Multiple Testing Problems in Regulatory Applications”

REFERENCES

• Bloch , D. A. , Lai , T. L. , Tubert-Bitter , P. ( 2001 ). One-sided tests in clinical trials with multiple endpoints . Biometrics 57 : 1039 – 1047 .
   PubMed Web of Science ®Google Scholar
• Chi , G. Y. H. ( 1998 ). Multiple testings: multiple comparisons and multiple endpoints . Drug Information Journal 32 : 1347S – 1362S .
   Google Scholar
• Chuang-Stein , C. , Stryszak , P. , Dmitrienko , A. , Offen , W. ( 2007 ). Challenge of multiple co-primary endpoints: a new approach . Statistics in Medicine 26 : 1181 – 1192 .
   PubMed Web of Science ®Google Scholar
• COZAAR Package Insert. Available at http://www.merck.com/product/usa/pi_circulars/c/cozaar/cozaar_pi.pdf .
   Google Scholar
• Dmitrienko , A. , Offen , W. , Westfall , P. H. ( 2003 ). Gatekeeping strategies for clinical trials that do not require all primary effects to be significant . Statistics in Medicine 22 : 2387 – 2400 .
   PubMed Web of Science ®Google Scholar
• Dmitrienko , A. , Molenberghs , G. , Chuang-Stein , C. , Offen , W. ( 2005 ). Analysis of Clinical Trials Using SAS: A Practical Guide . Cary , NC : SAS Press .
   Google Scholar
• Dmitrienko , A. , Wiens , B. L. , Tamhane , A. C. , Wang , X. ( 2007 ). Tree-structured gatekeeping tests in clinical trials with hierarchically ordered multiple objectives . Statistics in Medicine 26 : 2465 – 2478 .
   PubMed Web of Science ®Google Scholar
• Dmitrienko , A. , Tamhane , A. C. , Liu , L. , Wiens , B. L. ( 2008 ). A note on tree gatekeeping procedures in clinical trials . Statistics in Medicine 27 : 3446 – 3451 .
   PubMed Web of Science ®Google Scholar
• Eaton , M. L. , Muirhead , R. J. (2007). On a multiple endpoints testing problem. Journal of Statistical Planning and Inference 137:3416–3429.
   Web of Science ®Google Scholar
• Estrogen and estrogen/progestin drug products to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms—recommendations for clinical evaluation . ( 2003 ). FDA draft guidance for industry. Available at http://www.fda.gov/cder/guidance/index.htm#clinical%20medicine .
   Google Scholar
• ICH E9 ( 2000 ). Statistical principles for clinical trials. Step 5 guidance document available at http://www.ich.org .
   Google Scholar
• Offen , W. , Chuang-Stein , C. , Dmitrienko , A. , Littman , G. , Maca , J. , Meyerson , L. , Muirhead , R. , Stryszak , P. , Boddy , A. , Chen , K. , Copley-Merriman , K. , Dere , W. , Givens , S. , Hall , D. , Henry , D. , Jackson , J. D. , Krishen , A. , Liu , T. , Ryder , S. , Sankoh , A. J. , Wang , J. , Yeh , C. H. ( 2007 ). Multiple co-primary endpoints: Medical and statistical solutions. A report from the multiple endpoints expert team of the pharmaceutical research and manufacturers of America . Drug Information Journal 41 : 31 – 46 .
   Web of Science ®Google Scholar
• Patient-reported outcome measures: use in medical product development to support labeling claims . ( 2006 ). FDA draft guidance for industry. Available at http://www.fda.gov/cder/guidance/index.htm#clinical%20medicine
   Google Scholar
• Providing clinical evidence of effectiveness for human drug and biological products . ( 1998 ). FDA guidance for industry. Available at http://www.fda.gov/cder/guidance/index.htm#clinical%20medicine
   Google Scholar
• Snapinn , S. ( 2004 ). Considerations for Developing a Composite Endpoint . Presented at the PhRMA Workshop on Statistical, and Regulatory Challenges of Multiple Endpoints. October 20–21 , Washington , DC .
   Google Scholar
• Tamhane , A. C. , Logan , B. R. ( 2004 ). A superiority-equivalence approach to one-sided tests on multiple endpoints in clinical trials . Biometrika 91 : 715 – 727 .
   Web of Science ®Google Scholar